The current crop of drugs has modest benefits, and researchers are hunting for what's next.
— for all of the headlines, excitement and controversy it's caused — has limited effectiveness and potentially serious side effects, prompting researchers to look elsewhere.The fact that we've found drugs with any effectiveness against Alzheimer's is a huge deal, but the hunt for the holy grail is still on.
"Donanemab and related drugs caused a splash. But I think that now we're kind of moving on," said Keith Vossel, director of"The clinical uptake of these drugs has been slower than expected the moderate benefit that is offered, so that gives scientists more motivation to find news ways to slow the disease course."
Less than a fifth of total drugs under development — and 22% of those in Phase 3 trials — target amyloid.
Dementia Drugs Food And Drug Administration (FDA) Alzheimer’S Drug Discovery Foundation
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Here's an undervalued stock that can benefit from new Alzheimer's drugsThe Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Read more »
Tom Montgomery Fate: What it’s like to lose a father to Alzheimer’sThe hard thing with Alzheimer’s is that your dad or mom becomes like a child again, and you must parent them.
Read more »
Joe Grogan: Access to new Alzheimer’s treatments bogged down by Medicare policyThere are now two Alzheimer’s treatments with significant clinical benefit. It’s not clear how quickly patients will be able to benefit.
Read more »
Medicare Patients Unable To Get Alzheimer's Drug Sparks BacklashAlthough the FDA has determined lecanemab's benefits outweigh its risks in treating Alzheimer's, the CMS is pressing for more data on its efficacy and safety.
Read more »
Alzheimer’s blood test achieves faster diagnoses, high accuracy at Mayo ClinicMayo Clinic has announced a new, non-invasive blood test that detects a protein in the brain that signals Alzheimer’s. Doctors discuss how it offers a convenient, less invasive diagnostic alternative.
Read more »
Intensive Lifestyle Change Linked to Improved Alzheimer's SymptomsAfter 20 weeks of a multimodal lifestyle intervention, patients with MCI or early AD experienced improved cognition, results of a phase 2 trial suggested.
Read more »